397 related articles for article (PubMed ID: 33966583)
21. Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis.
Khurana A; Dalland JC; Young JR; Inwards DJ; Paludo J
Am J Hematol; 2021 Aug; 96(8):E298-E301. PubMed ID: 33984157
[No Abstract] [Full Text] [Related]
22. A woman with visual loss, amenorrhoea and polyuria: the first reported case of nodular lymphocyte-predominant Hodgkin lymphoma presenting with hypopituitarism.
Seymour M; Robertson T; Papacostas J; Morris K; Gillespie J; Norris D; Duncan EL
Endocrinol Diabetes Metab Case Rep; 2021 May; 2021():. PubMed ID: 33982665
[TBL] [Abstract][Full Text] [Related]
23. Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Tiacci E; De Carolis L; Simonetti E; Capponi M; Ambrosetti A; Lucia E; Antolino A; Pulsoni A; Ferrari S; Zinzani PL; Ascani S; Perriello VM; Rigacci L; Gaidano G; Della Seta R; Frattarelli N; Falcucci P; Foà R; Visani G; Zaja F; Falini B
N Engl J Med; 2021 May; 384(19):1810-1823. PubMed ID: 33979489
[TBL] [Abstract][Full Text] [Related]
24. Drugs for multiple sclerosis.
Med Lett Drugs Ther; 2021 Mar; 63(1620):42-48. PubMed ID: 33976089
[No Abstract] [Full Text] [Related]
25. Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC.
Huo MX; Avelino ARM; Singh G
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975832
[TBL] [Abstract][Full Text] [Related]
26. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Zimmerli A; Monti M; Fenwick C; Eckerle I; Beigelman-Aubry C; Pellaton C; Jaton K; Dumas D; Stamm GM; Infanti L; Andreu-Ullrich H; Germann D; Mean M; Vollenweider P; Stadelmann R; Prella M; Comte D; Guery B; Gachoud D; Rufer N
Front Immunol; 2021; 12():613502. PubMed ID: 33968017
[TBL] [Abstract][Full Text] [Related]
27. Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
Albert MH; Sirin M; Hoenig M; Hauck F; Schuetz C; Bhattacharyya R; Stepensky P; Jacoby E; Güngör T; Beier R; Schulz A
Bone Marrow Transplant; 2021 Sep; 56(9):2248-2258. PubMed ID: 33967276
[TBL] [Abstract][Full Text] [Related]
28. Screening and monitoring of the BTK
Bödör C; Kotmayer L; László T; Takács F; Barna G; Kiss R; Sebestyén E; Nagy T; Hegyi LL; Mikala G; Fekete S; Farkas P; Balogh A; Masszi T; Demeter J; Weisinger J; Alizadeh H; Kajtár B; Kohl Z; Szász R; Gergely L; Gurbity Pálfi T; Sulák A; Kollár B; Egyed M; Plander M; Rejtő L; Szerafin L; Ilonczai P; Tamáska P; Pettendi P; Lévai D; Schneider T; Sebestyén A; Csermely P; Matolcsy A; Mátrai Z; Alpár D
Br J Haematol; 2021 Jul; 194(2):355-364. PubMed ID: 34019713
[TBL] [Abstract][Full Text] [Related]
29. Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Renaud L; Bossard JB; Carpentier B; Terriou L; Cambier N; Chanteau G; Escure G; Tilmont R; Barbieux S; Wemeau M; Hieulle J; Boyle EM; Morschhauser F
Eur J Haematol; 2021 Sep; 107(3):370-373. PubMed ID: 34018260
[No Abstract] [Full Text] [Related]
30. Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax.
Rogers KA; Emond B; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P; Huang Q
Curr Med Res Opin; 2021 Aug; 37(8):1409-1420. PubMed ID: 34003049
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of novel substituted benzyl pyrrolopyrimidine derivatives as selective BTK inhibitors for treating mantle cell lymphoma.
Ran F; Liu Y; Chen X; Zhuo H; Xu C; Li Y; Duan X; Zhao G
Bioorg Chem; 2021 Jul; 112():104968. PubMed ID: 34000704
[TBL] [Abstract][Full Text] [Related]
32. Adherence to cardiovascular pharmacotherapy by patients in Iraq: A mixed methods assessment using quantitative dried blood spot analysis and the 8-item Morisky Medication Adherence Scale.
Alalaqi A; Lawson G; Obaid Y; Tanna S
PLoS One; 2021; 16(5):e0251115. PubMed ID: 33989336
[TBL] [Abstract][Full Text] [Related]
33. Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Pezzullo L; Giudice V; Serio B; Fontana R; Guariglia R; Martorelli MC; Ferrara I; Mettivier L; Bruno A; Bianco R; Vaccaro E; Pagliano P; Montuori N; Filippelli A; Selleri C
Open Med (Wars); 2021; 16(1):672-682. PubMed ID: 33981851
[TBL] [Abstract][Full Text] [Related]
34. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of inflammatory acquired demyelinating syndromes in children: a single-center experience.
Kilic H; Mavi D; Yalcinkaya BC; Yildiz EP; Kizilkilic O; Saltik S
Acta Neurol Belg; 2022 Dec; 122(6):1485-1491. PubMed ID: 33973168
[TBL] [Abstract][Full Text] [Related]
36. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy.
Sasaki M; Ishikawa T; Ishiguro M; Okazaki S; Yamauchi S; Kikuchi A; Matsuyama T; Kawada K; Tokunaga M; Uetake H; Kinugasa Y
Oncol Lett; 2021 Jun; 21(6):489. PubMed ID: 33968205
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Selvy M; Kerckhove N; Pereira B; Barreau F; Nguyen D; Busserolles J; Giraudet F; Cabrespine A; Chaleteix C; Soubrier M; Bay JO; Lemal R; Balayssac D
Front Pharmacol; 2021; 12():637593. PubMed ID: 33967771
[TBL] [Abstract][Full Text] [Related]
39. Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population.
Yang X; Khoo LP; Chang EWY; Yang VS; Poon E; Somasundaram N; Farid M; Tang TPL; Tao M; Lim ST; Chan JY
BMC Cancer; 2021 May; 21(1):566. PubMed ID: 34001056
[TBL] [Abstract][Full Text] [Related]
40. A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Cai J; Tian X; Ma S; Zhong L; Li W; Wang L; Guo L; Li Z; Wu Y; Zhong G; Huang H; Xia Z; Xia Y; Liu P; Su N; Fang Y; Zhang Y; Cai Q
Br J Cancer; 2021 Aug; 125(3):402-412. PubMed ID: 34012033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
